DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – By August 3, Congo’s Ebola outbreak had reached 3,874 confirmed cases and 1,751 deaths, marking the nation’s most extensive recorded epidemic. It ranks second globally, following only the 2014 to 2016 West Africa outbreak. Congo surpassed 1,000 confirmed cases within 40 days of initiating its response efforts, whereas the 2018 outbreak took approximately 235 days to reach the same milestone. The rapid escalation highlights issues such as delayed detection, insufficient surveillance, ongoing conflict, high mobility, and the lack of approved strain-specific medical interventions.
Congo’s Ministry of Public Health announced the outbreak on May 15 after laboratory testing identified Bundibugyo virus in Ituri province. The WHO first received an alert on May 5, following reports of a deadly, unexplained illness near Mongbwalu. Investigations later revealed that the virus had been circulating for months before officials recognized the outbreak. Initial testing in Bunia did not detect Bundibugyo, as early symptoms resembled malaria and other common febrile illnesses. This delay enabled infected individuals and their contacts to move through communities before isolation and contact tracing efforts could be expanded.
The viral species involved also influenced the response strategies. Existing licensed Ebola vaccines and antibody treatments are designed to target Zaire ebolavirus, responsible for Congo’s 2018 to 2020 epidemic. Currently, there are no approved vaccines or specific treatments for Bundibugyo virus disease. As a result, patient care relies heavily on early diagnosis, isolation, supportive therapy, infection prevention measures, contact tracing, and safe burial practices. Although the WHO has added a Bundibugyo diagnostic test to its emergency list and begun treatment studies, these measures came only after widespread transmission had already occurred.
Delayed detection hampers contact tracing efforts
The epidemic has expanded from Mongbwalu to 49 health zones across Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo. Ituri bears the brunt of cases and fatalities, with Bunia, Rwampara, and Mongbwalu being among the hardest hit regions. WHO tracked 17,863 contacts by July 30, yet only about three-quarters received active follow-up in several affected areas. Health officials also report that the majority of new infections are occurring outside known contact chains. Surveillance teams often identify new patients only after additional exposures have taken place.
Ongoing conflict and displacement complicate these efforts further. Armed attacks have hampered access, interrupted response activities, and caused some health teams to halt operations. Routes used for mining, trade, crowded displacement sites, and cross-border movement maintain large populations on the move through affected zones. Additionally, health facilities face shortages of protective gear, laboratory services, transportation, and trained personnel. As of July 30, Congo recorded 151 infections and 44 deaths among health workers. Some frontline workers have ceased operations in certain locations due to delayed or inadequate compensation.
Conflict and treatment deficiencies challenge containment efforts
Ebola transmission occurs through direct contact with the blood or bodily fluids of infected or deceased individuals. It does not spread via casual proximity like influenza. Transmission risk increases in clinics lacking robust infection control measures and during burials involving contact with infected bodies. Over 60% of recent deaths took place outside treatment centers, complicating efforts to conduct safe burials and contact investigations. To address this, Congo’s health authorities, WHO, and Africa CDC have expanded laboratory capacity, treatment centers, community outreach, and border surveillance. Nevertheless, the response lags behind the scale and velocity of the outbreak’s spread.
Uganda declared the end of its linked outbreak on July 28 after 42 days without a new locally transmitted case. The single case treated in France did not lead to secondary transmission, and the patient recovered. Congo remains the primary source of ongoing spread, with an early August confirmed case fatality rate of about 45%. The outbreak’s faster growth is attributed to late detection, incomplete contact tracing, and limited access due to insecurity. The absence of approved vaccines and treatments for Bundibugyo virus prevents the use of tools that previously helped contain Zaire Ebola epidemics. Collectively, these factors contribute to the unusually swift increase in cases.